Cyclical repair-&-remodel demand — a housing/consumer downturn hits volumes with operating leverage
One-line thesis. Masco is a well-run, high-margin, cash-generative maker of Behr paint and Delta/hansgrohe plumbing whose earnings grow mainly because it shrinks its share count — but the top line is flat-to-down (FY25 revenue −3.4%), the stock now sits at its 52-week high on a 78 RSI, and the fair value lands right on top of today's price, so this is a Watch: a quality business to own on weakness, not to chase here.
◆ Synthos call — HoldMAS is a solid business largely reflected at ~$82 — fine to keep, no reason to chase; it gets interesting again below ~$70.
Downside Risk (lower = safer)
5/10 · Moderate
Sturdy ~2.0× net-debt/EBITDA & 35% gross margin, but 1.28 beta, cyclical R&R demand, and now at a 52-wk high on 78 RSI.
Growth Quality
4/10 · Moderate
~9% forward EPS CAGR is buyback-driven — revenue is flat-to-down; margins high but mature.
Exponential Potential
2/10 · Low
A mature ~$7.6B-revenue cyclical with a flat top line; buybacks, not units, drive EPS — no exponential leg.
⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 9%/yrTo justify today’s $83, earnings would have to compound roughly 9% a year for 10 years (9% discount rate). Analysts forecast ~6%/yr, so the market is pricing in MORE than what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
Masco makes stuff that goes into homes: Behr paint (the one sold at Home Depot), Delta and hansgrohe faucets and showers, Liberty cabinet hardware, and HotSpring spas. When people repair and remodel their homes, Masco sells more; when they hold off, it sells less. It is a solid, profitable, boring company — it keeps about 35 cents of gross profit on every sales dollar and hands a lot of cash back to shareholders.
The catch: sales are not really growing — they actually dipped a bit last year. The reason earnings per share still creep up is that Masco keeps buying back its own stock, so the same profit is split among fewer shares. That is fine, but it is not the same as a growing business.
Right now the stock is about fairly priced — not a bargain — and it is trading at the very top of its yearly range after a strong run, which is usually a worse time to buy. So our verdict is Watch: a good company, but wait for a better price.
Here is what our three scores mean in everyday terms:
Downside Risk 5/10 (middle of the road). The balance sheet is sturdy and the business is steady, but it moves more than the market (it is cyclical) and it is priced full right now.
Growth Quality 4/10 (below average). Very profitable, but the top line is flat — the growth is mostly financial engineering, not more customers.
Exponential Potential 2/10 (low). This is a mature company in a mature market. Don't expect it to multiply; expect steady, modest returns.
The one big worry: Masco's sales rise and fall with home-improvement spending. If housing or the consumer weakens, volumes drop and — because a lot of costs are fixed — profits drop faster.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLY (sector)), set to 100 a year ago
Solid = MAS · dashed = S&P 500 · dotted = XLY (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$82.77
Market cap$17B
P/E trailing4×
P/E FY26E / FY27E19× / 18×
EV / Sales2.6×
EV / EBITDA13.8×
Gross margin35.4%
Net margin10.9%
Dividend yield1.52%
Beta1.282
52-wk range$59 – $83
RSI(14)79
50 / 200-DMA$72 / $68
12-mo return+23% (SPY +21%)
Street target$83 ($72–$97)
Analyst grades21 Buy · 15 Hold · 2 Sell
FMP ratingB-
Next earnings2026-08-05
What the experts actually said 0 traceable claims on MAS · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
Masco Corporation (NYSE: MAS), founded 1929, headquartered in Livonia, Michigan, is a global manufacturer and distributor of branded home-improvement and building products. It sells through home centers (notably Home Depot for Behr), wholesalers, e-commerce, and mass merchants. It runs two reporting segments. Fiscal year ends December 31.
Revenue mix (FY2025, from FMP segmentation):
By segment:Plumbing Products $4.99B (66%) — Delta, hansgrohe, KRAUS faucets/showers/valves, HotSpring spas, plumbing components, PEX tubing. Decorative Architectural Products $2.57B (34%) — Behr and KILZ paints/coatings, Liberty hardware, Kichler lighting.
By geography:North America $5.95B (79%) · Foreign locations $1.61B (21%). The business is North-America-centric, tied heavily to US repair-and-remodel (R&R) activity, with a smaller international (largely European plumbing) exposure.
Key structural point: Masco is weighted to repair-and-remodel, not new construction — historically the more stable of the two demand pools, but still cyclical and consumer-discretionary. Paint (Behr) and faucets are relatively repeatable, lower-ticket categories versus big-ticket remodels.
2. The expert thesis
There is no expert coverage of MAS in the Synthos knowledge base.total_claims = 0; there are zero net-bullish (or net-bearish) voices, and there are no claim_ids to cite. Per the Synthos house standard, we will not fabricate conviction we do not have.
What this means for the verdict: this note is entirely fundamentals- and quant-driven. The judgment rests on the reported financials (FMP), the analyst-consensus estimate path (labeled as estimates), the technical block, management's own SEC-filed guidance (half-weighted, §9), and standard valuation work — not on any distilled expert panel. Absence of KB coverage is itself information: MAS is a well-followed but low-drama mature cyclical that our expert-ingestion pipeline has not surfaced strong differentiated views on. Treat the conviction as Low accordingly.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
5 · Moderate
Net-debt/EBITDA ~2.0× and 35% gross margin make it sturdy, and 21× trailing / 13.8× EV-EBITDA isn't extreme — but beta 1.28, cyclical R&R demand, negative book equity from buybacks, and a 52-wk-high / 78-RSI entry raise near-term downside.
Growth Quality
4 · Below average
High margins and strong ROIC (~26%), but revenue is flat-to-down (FY25 −3.4%); ~9% forward EPS CAGR is buyback-driven, not organic volume — quality of the earnings growth is mediocre.
Exponential Potential
2 · Low
A mature ~$7.6B-revenue building-products maker in a mature market; the top line isn't accelerating and the share count, not units, drives EPS. No multibagger leg here.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores above summarize them.
Case
Key assumptions
Fair value
Bull
R&R demand re-accelerates; Plumbing keeps its ~7–9% local-currency momentum; margins expand ~100bps; buybacks continue. FY27E EPS beats to ~$5.00 (vs ~$4.70 cons); multiple re-rates to ~20×.
~$100 (+21%)
Base(our anchor)
Estimates roughly hit — FY27E EPS ~$4.70; flat-ish revenue, steady ~16–17% operating margin, buybacks continue; a mature high-quality cyclical earns a ~17.5× multiple.
~$82 (~0%)
Bear
Housing/consumer downturn; R&R volumes fall with operating deleverage; margins compress. FY27E EPS misses to ~$4.10; multiple de-rates to ~15×.
~$62 (−25%)
Synthos fair value = the base case, ~$82 (~flat), with the full $62–$100 span as the honest range. This anchor sits essentially on top of the Street's $82.6 consensus and today's $82.77 price — which is the whole point: after a +23% 12-month run to a 52-week high, MAS is priced for its base case with no margin of safety. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). MAS is neither an exponential nor even a fast compounder — it is a mature, capital-return cyclical:
Forward growth: revenue is flat-to-down — FY25 $7.56B, and consensus sees ~$7.77B (FY26E) → ~$8.02B (FY27E) → ~$8.39B (FY29E), a ~2.6% revenue CAGR off a lower FY25 base. EPS CAGR FY25→FY29E is ~9% ($3.86 → ~$5.47), but the gap between ~3% revenue growth and ~9% EPS growth is the buyback (share count fell from 219M diluted in FY24 to ~203M in Q1'26).
Acceleration (the 2nd derivative): revenue growth has been negative recently — FY23 $7.97B → FY24 $7.83B → FY25 $7.56B (−3.4%). Q1'26 finally turned up (+6% reported, +4% local currency). So there is a stabilization, not an inflection — no sustained acceleration to underwrite an exponential score.
Room to run: the US R&R / building-products TAM is large but mature and GDP-like; Masco already holds leading share in paint (Behr) and premium plumbing (Delta/hansgrohe). At $16.7B market cap the constraint isn't "room" — it's that the category itself grows low-single-digits.
Reinvestment runway: modest, disciplined capex (~$156M FY25, ~2% of sales) and bolt-on M&A; the dominant capital use is buybacks + dividend, which is the right call for a mature business but is the opposite of a reinvestment-for-growth story.
Exponential Potential: Low (2/10). Own MAS, if at all, for steady mid-single-digit-plus-buyback total return, not for growth. This honest framing is why MAS sits in the quality-cyclical satellite bucket, not any growth sleeve.
Revenue: FY25 $7.56B, −3.4% (FY24 $7.83B, −1.8% on FY23 $7.97B). A multi-year gentle decline off the 2022 peak ($8.68B) as the post-COVID R&R boom normalized. Q1'26 turned positive: $1.918B, +6% reported.
Quarterly trajectory: Q1'25 $1.80B → Q2 $2.05B → Q3 $1.92B → Q4 $1.79B → Q1'26 $1.92B (+6.5% YoY vs Q1'25). Normal seasonality (Q2 peak); the YoY turn is the tell to watch.
Margins: gross 35.4% TTM (stable, a durable brand/pricing signal), operating ~16.8%, EBITDA ~18.6%, net 10.9% TTM. Margins have held up well through the revenue decline — evidence of cost discipline and pricing power.
Earnings: net income $810M FY25 (EPS $3.86 diluted), down from $822M FY24 and $908M FY23 as revenue eased. Q1'26 net income to Masco $213M, EPS $1.05 (+21% YoY), a strong start.
Cash flow: operating CF $1.02B, capex −$156M, FCF ~$866M FY25 (FCF yield ~5.2%). Consistently converts >85% of operating cash to free cash — a genuinely cash-generative model.
Capital return: FY25 returned $571M in buybacks + $261M dividends = $832M — essentially all of free cash flow. Dividend $1.26/yr (~1.5% yield), payout ~31%.
Balance sheet: total debt $3.44B, cash $647M, net debt $2.79B, net-debt/EBITDA ~2.0× — moderate, investment-grade (letter rating B-/overall score 2 on FMP's model, dragged by leverage and negative book equity). Note: stockholders' equity is negative (−$186M) — an artifact of years of buybacks exceeding retained earnings, not distress; it makes ROE/P-B meaningless here (use ROIC/ROCE instead).
6. Valuation — priced in or room?
MAS is fairly-to-fully valued, not cheap and not egregious. Trailing 21× EPS, 2.6× EV/sales, 13.8× EV/EBITDA. On the forward estimate path the P/E steps down to 19× (FY26E) → 18× (FY27E) → ~15× (FY29E) — but note that de-rating is modest because the E only grows ~9%/yr and much of that is buyback. The PEG is unflattering (~2.1× on FMP's TTM figure) precisely because organic growth is low.
For a mature building-products name, ~13–14× EV/EBITDA is toward the higher end of the historical range — the market is paying up for margin resilience and the R&R stabilization, and the stock is at a 52-week high. A reverse read: at $82.77 the market is pricing continued mid-single-digit EPS growth with stable margins and ongoing buyback — i.e. the base case, fully. Street targets (context): consensus $82.6, high $97, low $72 — the consensus is essentially at the current price, confirming there is little discounted upside. Our ~$82 base FV agrees: no margin of safety at today's quote. This is a "wait for a pullback" valuation, not a "buy the dip" one.
7. Technicals (from the tech block)
Trend:up, but extended. $82.77 sits above the 50-DMA ($72.14) and 200-DMA ($67.77), 50 above 200 (golden-cross posture), MACD +3.19 (positive).
Location:at the 52-week high ($82.77, 0.0% off), +41% off the 52-week low ($58.60) — leadership posture, but no cushion; max drawdown from peak only −3.4%.
Momentum: RSI(14) 78.7 — overbought (>70). This is the clearest near-term caution flag: buying at a fresh high on a stretched RSI is a poor risk/reward entry.
Relative strength: MAS +23.4% 12-mo vs SPY +20.6% (roughly in line) but +36.4% 3-mo vs SPY +13.7% — a sharp recent acceleration, which is what has pushed RSI to overbought.
Read: technicals say the trend is healthy but the entry is stretched. A pullback toward the rising 50-DMA (~$72) would materially improve risk/reward and is more consistent with our flat base-case fair value. No technical reason to chase at $82.77.
8. Moat & competitive position
Masco's moat is brand + shelf-space + scale in a few defensible categories: (1) Behr is the dominant paint brand at Home Depot — an exclusive, high-volume home-center relationship that is hard to dislodge; (2) Delta / hansgrohe are top-tier plumbing brands with pricing power (35% gross margin held through a revenue decline is the proof); (3) distribution breadth across home centers, wholesale, and e-commerce. The limits: the categories are mature and cyclical, the key-customer concentration (Home Depot for paint) is a two-edged sword, and input costs (resins, metals) plus tariffs (management flags these explicitly) pressure margins.
Peer set (market cap, from FMP): Carlisle $14.8B, WESCO $15.0B, CNH $13.3B, Avery Dennison $12.8B, Mueller Industries $12.5B, Owens Corning $12.2B, Advanced Drainage $11.7B, TopBuild $9.9B, Builders FirstSource $9.1B. Within building products MAS is a higher-margin, more brand-driven, less new-construction-levered name than the framing/distribution peers (BLDR, BLD) — a relative quality-and-stability tilt rather than a growth tilt.
9. Management, capital allocation & guidance
Capital allocation: disciplined and shareholder-friendly — FY25 returned ~$832M (essentially all FCF) via $571M buybacks + $261M dividends, funded conservatively at ~2.0× net-debt/EBITDA. Share count is down ~7% YoY. This is a textbook mature-cash-cow allocation; the trade-off is that it signals limited high-return organic reinvestment.
Leadership: CEO Jon Nudi (President & CEO). Insider activity in the sampled window (filings 2026-05-12) is routine director equity awards (A-Award, price $0), not open-market conviction buys or alarming discretionary selling — neutral signal.
Management's own guidance (half-weighted — their book): From the SEC 8-K (Item 2.02) earnings release filed 2026-04-22, management is maintaining full-year 2026 guidance of reported EPS $3.91–$4.11 and adjusted EPS $4.10–$4.30. CEO Nudi: Q1 delivered "sales growth of 6 percent, adjusted operating profit growth of 13 percent, and adjusted EPS growth of 20 percent," and given "a dynamic macroeconomic and geopolitical environment" management thinks it "prudent to maintain" (not raise) the adjusted $4.10–$4.30 range. Honest weighting: this is management's self-interested framing (half-weight). The maintain-not-raise stance despite a strong Q1 is a tell that management sees macro/tariff uncertainty ahead — consistent with our flat base case. Our FY26E anchor (~$4.28 consensus) sits mid-range of their adjusted guide.
10. Catalysts & what to watch
Next earnings: 2026-07-29 (Q2'26; Street EPS $1.29, revenue ~$2.08B). Key line: whether the Q1 revenue turn (+6%) holds and whether management raises the maintained FY26 adjusted EPS guide — a raise would be the bull trigger.
R&R demand indicators: existing-home turnover, remodeling indices, and Home-Depot/Behr sell-through — the primary volume driver.
Margins vs tariffs/input costs: management explicitly flags tariff impact on demand, pricing, and product cost — watch gross margin holding ~35–36%.
Buyback pace: continued repurchase is doing much of the EPS work; a pause would remove a key EPS lever.
Plumbing momentum: Plumbing grew +9% local currency in Q1 vs Decorative flat — watch whether that divergence persists.
Thesis tripwires (what would change the call): two consecutive quarters of volume re-declines; gross margin slipping below ~34%; a guidance cut; or a buyback pause. Conversely, a guidance raise + sustained R&R re-acceleration would move this toward Buy — Tactical.
11. Key risks
Cyclicality (structural): R&R and building-products demand track housing turnover, rates, and consumer confidence; a downturn hits volumes with operating deleverage — the single biggest risk.
Valuation / no margin of safety: at a 52-week high, ~13.8× EV/EBITDA, and RSI 78.7, the stock prices the base case fully; disappointment de-rates it.
Customer concentration: heavy reliance on Home Depot (Behr) and a few large channels — a shelf-space or relationship shift would be material (management lists "reliance on key customers" as a named risk factor).
Tariffs & input costs: resins, metals, and tariff exposure pressure margins; management explicitly flags tariff impact on demand, pricing, and cost.
Flat top line / buyback dependence: if revenue doesn't reaccelerate, EPS growth leans entirely on buybacks, which are finite and less valuable as the multiple rises.
No expert coverage: zero KB voices means no independent conviction cross-check — the call is quant/fundamentals only, a lower-confidence posture by construction.
12. Verdict, position sizing & monitoring
Watch. Masco is a genuinely good business — 35% gross margin held through a revenue decline, ~5% FCF yield, disciplined all-of-FCF capital return, ~2.0× leverage, and top-tier brands (Behr, Delta, hansgrohe). But three facts keep it off the buy list today: (1) the top line is flat-to-down and EPS growth is largely buyback-manufactured; (2) the stock is at a 52-week high on an overbought 78 RSI after a +36% three-month run; and (3) our base-case fair value (~$82) and the Street consensus ($82.6) both land on top of the current price, leaving no margin of safety. There is no expert conviction to override the quant read.
Sizing: if owned, satellite/quality-cyclical, ~1–2% at most, and better initiated on a pullback toward the 50-DMA (~$72) rather than at the high.
Monitoring: re-underwrite on the §10 tripwires; formal re-score at the 2026-07-29 print. A guidance raise + sustained R&R re-acceleration would upgrade toward Buy — Tactical; a volume re-decline or margin slip would push toward Avoid.
Single biggest risk: cyclical R&R demand — a housing/consumer downturn hits volumes with operating leverage.
This verdict is logged as a tracked Synthos call as of 2026-07-03 at $82.77.
Provenance & disclosures
Traceability:0 KB claims, breadth 0 — there is no expert coverage of MAS in the Synthos knowledge base, so no claim_ids are cited and none are fabricated. The verdict is explicitly fundamentals- and quant-driven.
Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · management guidance from the SEC 8-K filed 2026-04-22. Forward figures are analyst consensus (FMP) or our scenario model, labeled as estimates.
Management caveat: management's maintained FY26 adjusted-EPS guidance ($4.10–$4.30) is management's own book, half-weighted by design.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").